Press releases | Finanzwire

Basculer en Français

10374	Companies
216189	Keywords
145888	Articles
114464	Press releases

Home
Press releases

PRESS RELEASE

published on 01/26/2024 at 08:35, 2 years 3 months ago

Transaction in Own Shares
Nordea Bank Abp completed a repurchase of its own shares on 25.01.2024, in accordance with the buy-back program. Details of the transactions can be found in the announcement.

Share Repurchase Treasury Shares Nordea Bank Abp Buy-back Program Stock Exchange Release
PRESS RELEASE

published on 01/26/2024 at 08:30, 2 years 3 months ago

Ondine Unveils New Research at SPIE Photonics West
Ondine Biomedical Inc. will present new research on photodisinfection and nasal decolonization at the SPIE Photonics West conference in San Francisco, California. The presentation will showcase the effectiveness of Steriwave as a nasal decolonization method.

Ondine Biomedical Inc. SPIE Photonics West Photodisinfection Nasal Decolonization Steriwave
PRESS RELEASE

published on 01/26/2024 at 08:00, 2 years 3 months ago

Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc purchased 120,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange through Numis Securities Ltd, as part of its share buyback program.

Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin Numis Securities Ltd
PRESS RELEASE

published on 01/26/2024 at 08:00, 2 years 3 months ago

Superdry plc: FY24 Half Year Results
Superdry plc announces challenging H1 FY24 results with 23.5% revenue decline due to consumer retail market and unseasonal weather. The company focuses on cost and inventory reduction for long-term success.

Superdry Plc Cost Reduction H1 FY24 Results Revenue Decline Inventory Reduction
PRESS RELEASE

published on 01/26/2024 at 08:00, 2 years 3 months ago

Superdry plc: Directorate Change
Superdry plc announces the resignation of Shaun Wills as CFO and the appointment of Giles David as Interim CFO, with a smooth transition expected over the next two months.

CFO Superdry Plc Directorate Change Shaun Wills Giles David
PRESS RELEASE

published on 01/26/2024 at 08:00, 2 years 3 months ago

MESH Automation to Showcase Innovative Cobot Depalletizing and Palletizing Solutions at MODEX 2024
MESH Automation to showcase advanced cobot depalletizing and palletizing solutions at MODEX 2024 Show, emphasizing commitment to automation in manufacturing and distribution. Visit booth A12327 for live demonstrations and interactive experiences.

MESH Automation MODEX 2024 Cobot Depalletizing Palletizing
PRESS RELEASE

published on 01/26/2024 at 07:01, 2 years 3 months ago

Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza
Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza. Longstanding Chairman Albert Baehny to step down at the 2024 AGM. Key figure in Lonza's transformation to a healthcare manufacturing leader.

Lonza Jean-Marc Huët Albert M. Baehny Chairman Healthcare Manufacturing
PRESS RELEASE

published on 01/26/2024 at 07:00, 2 years 3 months ago

SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory
SCHOTT Pharma AG & Co. KGaA delivers on 2023 targets with 9% revenue growth to EUR 899m and maintains high EBITDA margin of 26.6%. Strategic shift towards high-value solutions accelerates with strong profitability.

Revenue Growth EBITDA Margin SCHOTT Pharma Annual Report Forecast
PRESS RELEASE

published on 01/26/2024 at 07:00, 2 years 3 months ago

Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028
Sartorius expects profitable growth in 2024 with double-digit annual sales revenue growth projected through to 2028. Sales revenue declined in 2023 due to soft demand and geopolitical uncertainties. Rapid leverage reduction through strong operating cash flow planned.

2023 Results 2024 Guidance Sartorius Profitable Growth Sales Revenue
PRESS RELEASE

published on 01/26/2024 at 07:00, 2 years 3 months ago

Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook. The company expects sales revenue growth in the mid to high single-digit percentage range with an underlying profit margin of more than 30 percent. Keywords: Sartorius Stedim Biotech, preliminary results, fiscal 2023, 2024 guidance, midterm outlook.

Preliminary Results Sartorius Stedim Biotech Fiscal 2023 2024 Guidance Midterm Outlook

Accesswire

Published on 05/09/2026 at 01:55, 1 day 17 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 17 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 17 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 19 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 19 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/10/2026 at 16:05, 2 hours 54 minutes ago

RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 4 hours 59 minutes ago

MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 7 hours 14 minutes ago

Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 23 hours 54 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 22 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations

Les Echos

Published on 05/07/2026 at 19:15, 2 days 23 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 2 days 23 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 3 days ago

DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 18:12, 3 days ago

LNA SANTE : Q1 2026
Published on 05/07/2026 at 17:45, 3 days 1 hour ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE